The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlpha Growth Regulatory News (ALGW)

Share Price Information for Alpha Growth (ALGW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.80
Bid: 1.70
Ask: 1.90
Change: 0.60 (50.00%)
Spread: 0.20 (11.765%)
Open: 1.20
High: 1.85
Low: 1.20
Prev. Close: 1.20
ALGW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Colva

1 Mar 2019 07:00

RNS Number : 5169R
Alpha Growth PLC
01 March 2019
 

1 March 2019

Alpha Growth plc

("Alpha", or the "Company")

 

Acquisition of Colva

 

Alpha Growth plc (LSE: ALGW), the financial services specialist in the growing Senior Life Settlement ("SLS") asset class, is pleased to announce the acquisition of Colva Insurance Services Corp. ("Colva").

The Company has signed an agreement for the acquisition of the entire ordinary share capital of Colva. Colva is a specialist actuarial service provider to the SLS industry and has a number of key clients, primarily based in the US.

The major shareholder of Colva is Rajiv Rebello, who founded Colva in order to use his first hand actuarial and life insurance expertise to minimize premium payments and maximize returns for life insurance and life settlement investors. Rajiv is a Fellow of the Society of Actuaries (FSA) and prior to Colva worked on AIG's 4,000+ policy life settlement portfolio with $18 billion in face. Prior to AIG, Rajiv worked at New York Life helping to price, design and create illustration software for their Universal Life and Variable Universal Life products. While at New York Life, Rajiv was also involved in analyzing mortality and lapse data experience and the creation of a new mortality table for New York Life. Colva is incorporated in California, USA, company number 3404971.

Alpha will acquire the entire share capital of Colva for a total consideration of £77,727 which shall be settled through the issue of 3,985,985 new ordinary shares of 0.1 pence each in the Company at an issue price of 1.95p per share, being the closing price of Alpha's shares on the day heads of terms were agreed. The shares will be issued and admitted for trading on the one year anniversary of the acquisition, subject to Rajiv continuing to be commercially engaged with Alpha on the issue date.

Further announcements will be made in due course.

 

Gobind Sahney, Chairman commented:

"The acquisition of Colva includes the addition of Rajiv who will become our Chief Actuary and Director of Investment Analytics. Rajiv is a terrific addition to the team and expands our in-house abilities to provide clients with superior advise and guidance on longevity assets. We welcome Rajiv and the clients that Colva works with to the Alpha team."

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

For more information, please visit www.algwplc.com or contact the following:

 

Alpha Growth plc

+44 (0) 20 3959 8600

Gobind Sahney, Executive Chairman

info@algwplc.com

 

 

Vox Markets (Digital IR)

+44 (0) 203 865 0130

Abraham Darwyne

content@voxmarkets.co.uk

 

 

Novum Securities Limited (Corporate Broker)

+44 (0) 207 399 9400

Colin Rowbury

crowbury@novumsecurities.com

 

About Alpha Growth plcSpecialist in Longevity AssetsAlpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, Alpha Growth has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The Company's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide wholistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQDBGDDDGDBGCI
Date   Source Headline
23rd Mar 20214:36 pmRNSPrice Monitoring Extension
23rd Mar 20212:06 pmRNSSecond Price Monitoring Extn
23rd Mar 20212:00 pmRNSPrice Monitoring Extension
23rd Mar 202111:05 amRNSSecond Price Monitoring Extn
23rd Mar 202111:00 amRNSPrice Monitoring Extension
23rd Mar 20219:05 amRNSSecond Price Monitoring Extn
23rd Mar 20219:00 amRNSPrice Monitoring Extension
23rd Mar 20217:00 amRNSCompletion of Share Purchase Acquisition
17th Mar 20214:41 pmRNSSecond Price Monitoring Extn
17th Mar 20214:36 pmRNSPrice Monitoring Extension
16th Mar 20217:00 amRNSHolding(s) in Company
16th Mar 20217:00 amRNSHolding(s) in Company
16th Mar 20217:00 amRNSHolding(s) in Company
8th Mar 20217:00 amRNSIssue of Placing Shares
5th Mar 202112:00 pmRNSResults of the Annual General Meeting
11th Feb 20214:41 pmRNSSecond Price Monitoring Extn
11th Feb 20214:35 pmRNSPrice Monitoring Extension
11th Feb 20212:06 pmRNSSecond Price Monitoring Extn
11th Feb 20212:00 pmRNSPrice Monitoring Extension
11th Feb 202111:06 amRNSSecond Price Monitoring Extn
11th Feb 202111:00 amRNSPrice Monitoring Extension
11th Feb 20217:00 amRNSStrategic Acquisition and Company Update
5th Feb 20214:42 pmRNSSecond Price Monitoring Extn
5th Feb 20214:36 pmRNSPrice Monitoring Extension
5th Feb 20212:06 pmRNSSecond Price Monitoring Extn
5th Feb 20212:01 pmRNSPrice Monitoring Extension
20th Jan 20216:27 pmRNSHolding(s) in Company
15th Jan 20219:05 amRNSSecond Price Monitoring Extn
15th Jan 20219:00 amRNSPrice Monitoring Extension
15th Jan 20217:00 amRNSBlackOak Alpha Growth Fund Year End Results
7th Jan 20214:36 pmRNSPrice Monitoring Extension
4th Jan 20217:00 amRNSFurther re 2020 Annual Report
31st Dec 202011:05 amRNSSecond Price Monitoring Extn
31st Dec 202011:00 amRNSPrice Monitoring Extension
31st Dec 20209:00 amRNSAnnual Financial Report
18th Dec 202011:05 amRNSSecond Price Monitoring Extn
18th Dec 202011:00 amRNSPrice Monitoring Extension
18th Dec 20207:00 amRNSHolding(s) in Company
16th Dec 202011:05 amRNSSecond Price Monitoring Extn
16th Dec 202011:00 amRNSPrice Monitoring Extension
16th Dec 20207:00 amRNSOTC Listing
15th Dec 20202:05 pmRNSSecond Price Monitoring Extn
15th Dec 20202:00 pmRNSPrice Monitoring Extension
11th Dec 202011:05 amRNSSecond Price Monitoring Extn
11th Dec 202011:00 amRNSPrice Monitoring Extension
10th Dec 20204:41 pmRNSSecond Price Monitoring Extn
10th Dec 20204:36 pmRNSPrice Monitoring Extension
9th Dec 20202:06 pmRNSSecond Price Monitoring Extn
9th Dec 20202:01 pmRNSPrice Monitoring Extension
30th Nov 20204:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.